CalEthos, Inc. financials

GEDC CIK 0001174891

Source: EDGAR filings · Built 2026-06-19T00:57:47Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Working Capital -2.80M -219.00K -704.00K -3.14M -578.00K -1.32M
Net Debt 1.29M 1.04M 33.00K -1.76M 40.00K
Return on Equity (ROE) 232.07% -291.64% -297.18% -69.39% 1249.81% 57.14%
Return on Assets (ROA) -2202.71% -204.88% -179.46% 105.31% -218.27% -37800.00%
Current Ratio 0.10× 0.57× 0.31× 0.40× 0.84× 0.00×
Debt-to-Equity -0.56× 0.31× 0.22× -0.10× -5.72× -0.53×
Cash Conversion Ratio 0.12× 0.07× 0.01× -0.38× 0.08× 0.24×
Accruals Ratio -19.48× -1.91× -1.78× 1.45× -2.00× -287.00×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 0
Operating Expenses 1.05M 1.06M 3.46M -3.92M 6.15M 391.00K
Operating Income (Loss) -1.05M -1.06M -3.46M 3.92M -6.15M -391.00K
Net Income (Loss) Attributable to Parent -6.50M -12.59M -4.63M 2.18M -6.75M -756.00K
Earnings Per Share, Basic $-0.25 $-0.50 $-0.24 $0.15 $-0.35
Weighted Average Number of Shares Outstanding, Basic 25.73M 25.15M 19.16M 14.50M 19.48M
Earnings Per Share, Diluted $-0.25 $-0.50 $-0.24 $0.08 $-0.35
Weighted Average Number of Shares Outstanding, Diluted 25.73M 25.15M 19.16M 29.34M 19.48M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 287.00K 286.00K 308.00K 2.07M 3.05M
Assets, Current 295.00K 296.00K 318.00K 2.07M 3.05M 2.00K
Assets 295.00K 6.14M 2.58M 2.07M 3.09M 2.00K
Liabilities, Current 3.10M 515.00K 1.02M 5.21M 3.63M 1.32M
Liabilities 3.10M 1.83M 1.02M 3.63M 1.32M
Stockholders' Equity Attributable to Parent -2.80M 4.32M 1.56M -3.14M -540.00K -1.32M
Common Stock, Shares, Outstanding 25.73M 25.73M 24.35M 24.50M 26.00M 16.63M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -750.00K -859.00K -35.00K -820.00K -565.00K -182.00K
Net Cash Provided by (Used in) Investing Activities -464.00K -1.47M -1.73M -105.00K -38.00K
Net Cash Provided by (Used in) Financing Activities 1.22M 2.31M -50.00K 3.65M 59.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GEDC CIK 0001174891), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RCUS

Arcus Biosciences, Inc.

ASCRF

ASPAC II Acquisition Corp.

HBIO

HARVARD BIOSCIENCE INC